Adverse reaction for dengue drugs

Adverse drug reaction as "an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product." Such reactions are currently reported by use of WHO's Adverse Reaction Terminology, which will eventually become a subset of the International Classification of Diseases. Adverse drug reactions are classified into six types (with mnemonics): dose-related (Augmented), non-dose-related (Bizarre), dose-related and time-related (Chronic), time-related (Delayed), withdrawal (End of use), and failure of therapy (Failure). Timing, the pattern of illness, the results of investigations, and rechallenge can help attribute causality to a suspected adverse drug reaction. Management includes withdrawal of the drug if possible and specific treatment of its effects. Suspected adverse drug reactions should be reported. Surveillance methods can detect reactions and prove associations.

 

  • Injection site reactions
  • Drug Safety and Dosage
  • Bleeding risk in dengue

Related Conference of Adverse reaction for dengue drugs

March 27-28, 2024

6th International Conference on Digital Health

London, UK
April 24-25, 2024

35th European Heart and Heart Failure Congress

Paris, France
June 21-22, 2024

52nd Global Nursing & Healthcare Conference

Rome, Italy
September 09-10, 2024

3rd Global Summit on Physiology and Metabolism of Thyroid

Paris, France
September 18-19, 2024

29th International Conference on Skincare and Cosmetology

Amsterdam, Netherlands
September 19-20, 2024

20th Global Biomarkers and Clinical Research Summit

Amsterdam, Netherlands
September 24-25, 2024

5th Global Summit on Public Health

Paris, France

Adverse reaction for dengue drugs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in